Indegene Acquires BioPharm for $106M to Boost Commercialization Portfolio
Indegene Ltd has announced a significant acquisition, agreeing to buy US marketing services company BioPharm Parent Holding Inc for approximately $106 million in cash. This deal is set to bolster Indegene's commercialization portfolio and strengthen its position in the omnichannel and media space.
BioPharm, established in 2005, specializes in providing omnichannel strategy, end-to-end media journey, and data-driven campaign execution for major global biopharma companies. In the financial year ended December 2024, BioPharm achieved a commendable revenue growth of 6% to $38.13 million. Indegene, founded in 1998, sees this acquisition as an opportunity to enhance its service offerings with BioPharm's advanced tech capabilities and deep therapeutic expertise.
Indegene's Chairman and CEO, Manish Gupta, praised BioPharm's impressive growth flywheel and expressed confidence in the acquisition's potential. This move comes after Indegene's previous acquisitions of medical writing consultancy firms and other service providers to expand its offerings. Indegene went public last year through an IPO that included an offer for sale by PE firms Carlyle and Brighton Park Capital, and Infosys co-founder Nadathur S Raghavan's family office. Carlyle has since fully exited the company, with current investors including Brighton Park, the Nadathur Family Office, and PremjiInvest.
The acquisition of BioPharm by Indegene is expected to provide a significant boost to Indegene's commercialization models, combining rich data assets to drive higher media ROI and enable more effective agentic operations. This deal underscores Indegene's commitment to expanding its service offerings and strengthening its position in the competitive biopharma marketing services landscape.
Read also:
- Crooked House Pub's Demolition: Council Orders Rebuild, Debate on Historic Building Protections
- Shaping India's Economic Progression: Readying the Financial System for Tomorrow
- Conflict between Ben & Jerry's co-founder and Unilever over Gaza issues leads to resignation of co-founder
- Tesla Expands Supercharger Network in Canada by Over 630 Stalls by 2025
